Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE

Condition:   Antiphospholipid Syndrome Interventions:   Drug: Telitacicept;   Drug: Rituximab;   Drug: Aspirin;   Drug: Warfarin;   Drug: Hydroxychloroquine;   Drug: Prednisone Sponsor:   Qilu Hospital of Shandong University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials